Anaplastic astrocytomas: survival and prognostic factors in a surgical series.

about

Adjuvant temozolomide-based chemoradiotherapy versus radiotherapy alone in patients with WHO III astrocytoma: The Mainz experience.Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Anaplastic Gliomas: Indian Single-center Data.

P2860

Q40889118-163B0190-F70E-4A8A-9ED8-853769CF48BC Q47732901-B08AF125-E0CE-4DEE-91E0-D7A5934A9F86

P2860

Anaplastic astrocytomas: survival and prognostic factors in a surgical series.

Item

http://www.wikidata.org/entity/Q44354958

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Anaplastic astrocytomas: survival and prognostic factors in a surgical series.

@en

Anaplastic astrocytomas: survival and prognostic factors in a surgical series.

@nl

type

Item

label

Anaplastic astrocytomas: survival and prognostic factors in a surgical series.

@en

Anaplastic astrocytomas: survival and prognostic factors in a surgical series.

@nl

prefLabel

Anaplastic astrocytomas: survival and prognostic factors in a surgical series.

@en

Anaplastic astrocytomas: survival and prognostic factors in a surgical series.

@nl

P1476

Anaplastic astrocytomas: survival and prognostic factors in a surgical series.

@en

P2093

Ane Konglund

http://www.w3.org/2001/XMLSchema#string

David Scheie

http://www.w3.org/2001/XMLSchema#string

Siril G Rogne

http://www.w3.org/2001/XMLSchema#string

P2860

The 2007 WHO classification of tumours of the central nervous system

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.

Survival and prognostic factors of anaplastic gliomas.

Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers

P2888

s00701-014-2053-5

P304

1053-1061

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00701-014-2053-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

156

http://www.w3.org/2001/XMLSchema#string

P50

Torstein R. Meling

Eirik Helseth

P577

2014-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24682619

http://www.w3.org/2001/XMLSchema#string

Anaplastic astrocytomas: survival and prognostic factors in a surgical series.

about

P2860

P2860

Anaplastic astrocytomas: survival and prognostic factors in a surgical series.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698